LIPOCINE INC. Increase (Decrease) in Deferred Revenue
LIPOCINE INC. (LPCN) reported Increase (Decrease) in Deferred Revenue of $320.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-03-10
- LIPOCINE INC. increase (decrease) in deferred revenue for the quarter ending 2013-12-31 was $0.00.
- LIPOCINE INC. increase (decrease) in deferred revenue for the quarter ending 2012-12-31 was $0.00.
- LIPOCINE INC. increase (decrease) in deferred revenue for fiscal 2024 was $320.00K.
- LIPOCINE INC. increase (decrease) in deferred revenue for fiscal 2013 was $0.00.
- LIPOCINE INC. increase (decrease) in deferred revenue for fiscal 2012 was -$7.52M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|
| 2024-12-31 | $320.00K 10-K · filed 2026-03-10 | ||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $0.00 10-K · filed 2014-03-31 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-13 | ||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$7.52M 10-K · filed 2014-03-31 | |
| 2012-09-30 | -$7.52M 10-Q · filed 2013-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |